Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Non-significant updates observed, including a newer last update timestamp and minor formatting changes. Core study details such as objectives, eligibility criteria, endpoints, and enrollment remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:25:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:35:14.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:52.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:42:37.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-06T15:25:00.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various medical compounds and proteins related to small cell lung carcinoma. Notably, previous content related to lung cancer genetics and various antineoplastic agents has been removed.
    Difference
    4%
    Check dated 2025-08-30T12:01:28.000Z thumbnail image

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.